Neogenix Oncology's registration statement on Form 10 filed with SEC becomes effective

Neogenix Oncology announced today that its registration statement on Form 10 as amended, filed with the Securities and Exchange Commission (SEC) to register its common stock pursuant to Section 12(g) of the Securities Exchange Act of 1934, has become effective. The Form 10 includes a description of the business of the company, management's discussion and analysis of financial condition, financial statements for the past two years and the first quarter of 2010, as well as other legal and financial disclosures such as risk factors. With the effectiveness of the Form 10, the Company has become a public reporting company under the Securities Exchange Act of 1934. The Form 10 is available through the public website of the SEC at www.sec.gov and the Company's website, found at www.neogenix.com or www.neogenix.us. As a public reporting company, the Company will be required to prepare and file with the SEC annual, quarterly and current reports as well as comply with the SEC's proxy rules and other securities laws.

The Company was required to file the Form 10 because it had more than 500 shareholders of record and more than $10 million of total assets at the end of 2009 as a result of the many private placement financings that is has completed since the Company was formed. The Company has not completed a registered public offering of any of its securities and the Company's common stock is not listed on any exchange or market. The Company will continue to have financing needs in the future and will continue to consider all available alternatives to raise funds, including but not limited to, an initial public offering, private placements, offerings of debt securities, strategic investments and joint ventures or collaborative arrangements. The Company cannot provide any assurance that it will successfully complete any of such financing alternatives. The Company expressly undertakes no obligation to update or revise any of the information or statements in this paragraph, whether as a result of new information, future events or otherwise.